1. Companies

  2. Sharp Peptide Biotechnology (Dalian) Group

Sharp Peptide Biotechnology (Dalian) Group

Sharp Peptide Biotechnology (Dalian) Group

Launch date
Market cap
-
Enterprise valuation
$16—24m (Dealroom.co estimates May 2023.)
Dalian Liaoning (HQ)
    • Edit
DateInvestorsAmountRound
*

$4.0m

Series A
Total Funding$4.0m

Recent News about Sharp Peptide Biotechnology (Dalian) Group

Edit